Remedee Labs

Executive Summary

Remedee Labs is a French medical device company developing a non-invasive millimeter wave neuromodulation technology that stimulates endorphin release to manage chronic pain and other conditions. Founded in 2016 and based in Grenoble, the company combines its wearable device with a digital services platform and multidisciplinary support to offer personalized treatment. The technology aims to provide a drug-free alternative to pain management, addressing a large market. However, the company is private and early-stage, with limited public information on funding or revenue. Its scientific approach is promising, but clinical validation and regulatory clearances remain critical milestones.

Upcoming Catalysts (preview)

• Q3 2026Publication of pivotal clinical trial results70% success
• Q4 2026CE marking certification for the wearable device60% success
• Q3 2026Strategic partnership with a major healthcare provider or distributor50% success